Literature DB >> 24100272

Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells.

Ke Liang1, Songbo Qiu1, Yang Lu1, Zhen Fan1.   

Abstract

Recent studies suggest that erythropoietin (EPO) has pleiotropic effects in several cell types in addition to hematopoietic cells; however, the role of EPO-mediated cell signaling in nonhematopoietic cells, including in cancer cells, remains controversial. Here, we report our findings of autocrine/paracrine production of EPO by breast cancer cells and its functional significance. We detected a significant level of autocrine/paracrine EPO in the conditioned medium from the culture of SKBR3 breast cancer cells, particularly when the cells were cultured in hypoxia. Through knockdown of EPO and EPO receptor expression and experimental elevation of EPO receptor expression in SKBR3 breast cancer cells, we demonstrated novel roles of autocrine/paracrine EPO-mediated cell signaling in regulating migration and invasion potential and stemness-like properties of breast cancer cells.

Entities:  

Keywords:  autocrine/paracrine loop; breast cancer; erythropoietin; migration and invasion; stemness

Mesh:

Substances:

Year:  2013        PMID: 24100272      PMCID: PMC3938527          DOI: 10.4161/cbt.26717

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  50 in total

1.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

2.  Erythropoietin stimulates proliferation of human renal carcinoma cells.

Authors:  C Westenfelder; R L Baranowski
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

3.  Involvement of hypoxia-inducible factor 1 in human cancer.

Authors:  Gregg L Semenza
Journal:  Intern Med       Date:  2002-02       Impact factor: 1.271

4.  Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

Authors:  T J Littlewood; E Bajetta; J W Nortier; E Vercammen; B Rapoport
Journal:  J Clin Oncol       Date:  2001-06-01       Impact factor: 44.544

Review 5.  Hypoxia-induced pathways in breast cancer.

Authors:  T I Goonewardene; H M Sowter; A L Harris
Journal:  Microsc Res Tech       Date:  2002-10-01       Impact factor: 2.769

6.  Functional significance of erythropoietin receptor expression in breast cancer.

Authors:  Murat O Arcasoy; Khalid Amin; Aysen F Karayal; Shu-Chuan Chou; James A Raleigh; Mahesh A Varia; Zishan A Haroon
Journal:  Lab Invest       Date:  2002-07       Impact factor: 5.662

7.  Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.

Authors:  Francisco Ferro de Beça; Pedro Caetano; Renê Gerhard; Cesar Augusto Alvarenga; Madalena Gomes; Joana Paredes; Fernando Schmitt
Journal:  J Clin Pathol       Date:  2012-10-30       Impact factor: 3.411

Review 8.  Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis.

Authors:  H J Knowles; A L Harris
Journal:  Breast Cancer Res       Date:  2001-07-17       Impact factor: 6.466

Review 9.  Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer.

Authors:  N S Brown; R Bicknell
Journal:  Breast Cancer Res       Date:  2001-07-23       Impact factor: 6.466

10.  Contrasting hypoxic effects on breast cancer stem cell hierarchy is dependent on ER-α status.

Authors:  Hannah Harrison; Lynsey Rogerson; Hannah J Gregson; Keith R Brennan; Robert B Clarke; Göran Landberg
Journal:  Cancer Res       Date:  2012-12-17       Impact factor: 12.701

View more
  8 in total

1.  Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.

Authors:  Jingtao Luo; Yun Hong; Yang Lu; Songbo Qiu; Bharat K R Chaganty; Lun Zhang; Xudong Wang; Qiang Li; Zhen Fan
Journal:  Cancer Lett       Date:  2016-09-28       Impact factor: 8.679

2.  Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.

Authors:  Tania Romina Stoyanoff; Juan Pablo Rodríguez; Juan Santiago Todaro; Joaquín Diego Espada; Juan Pablo Melana Colavita; Nora Cristina Brandan; Adriana Mónica Torres; María Victoria Aguirre
Journal:  Tumour Biol       Date:  2016-07-28

3.  Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.

Authors:  Zhihong Ai; Yang Lu; Songbo Qiu; Zhen Fan
Journal:  Cancer Lett       Date:  2016-01-19       Impact factor: 8.679

4.  Erythropoietin enhances migration of human neuroblastoma cells: in vitro studies and potential therapeutic implications.

Authors:  Agata Poniewierska-Baran; Justyna Rajewska-Majchrzak; Mariusz Z Ratajczak
Journal:  J Cancer Stem Cell Res       Date:  2017-04-27

Review 5.  Epoetin beta for the treatment of chemotherapy-induced anemia: an update.

Authors:  Luca Galli; Clara Ricci; Colin Gerard Egan
Journal:  Onco Targets Ther       Date:  2015-03-05       Impact factor: 4.147

6.  Combination with intravenous iron supplementation or doubling erythropoietin dose for patients with chemotherapy-induced anaemia inadequately responsive to initial erythropoietin treatment alone: study protocol for a randomised controlled trial.

Authors:  Lin Chen; Hong Jiang; Wei Gao; Ye Tu; Ying Zhou; Xi Li; Zhe Zhu; Qixin Jiang; Haifeng Zhan; Jiangming Yu; Chuangang Fu; Yong Gao
Journal:  BMJ Open       Date:  2016-10-07       Impact factor: 2.692

7.  Local blockage of self-sustainable erythropoietin signaling suppresses tumor progression in non-small cell lung cancer.

Authors:  Lei He; Shouzhen Wu; Qiang Hao; Elhadji M Dioum; Kuo Zhang; Cun Zhang; Weina Li; Wei Zhang; Yingqi Zhang; Jiming Zhou; Zhijun Pang; Lijuan Zhao; Xiaowen Ma; Meng Li; Qiuyang Zhang
Journal:  Oncotarget       Date:  2017-07-18

8.  Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer.

Authors:  Abderrahim El Guerrab; Anne Cayre; Fabrice Kwiatkowski; Maud Privat; Jean-Marc Rossignol; Fabrice Rossignol; Frédérique Penault-Llorca; Yves-Jean Bignon
Journal:  PLoS One       Date:  2017-04-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.